Lumicell Stock

lumicell.comHealthcare / Other HealthcareFounded: 2009Funding to Date: $165.24MM

Lumicell is a provider image-guided cancer surgery, offering technology that illuminates cancer cells in the tumor cavity, enabling physicians to take action in real time to improve patient outcomes.

Register To Buy and Sell Shares

For more details on financing and valuation for Lumicell, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Lumicell’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Lumicell.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Kelly Londy
Chief Executive Officer & Operational Executive, Board of Directors
Felix Geissler
Chief Medical Officer
Kevin Hershberger
Chief Financial Officer
David Strasfeld Ph.D
Director, Research & Development
W. David Lee
Co-Founder, President, Chief Scientific Officer & Board Member
Jorge Ferrer Ph.D
Senior Vice President, Research & Development

Board Members

Andrey Zarur Ph.D
Kodiak Venture Partners
Kelly Londy
Moungi Bawendi Ph.D
Jim Schuermann
Michael Ruettgers
Ralph Weissleder Ph.D
David Furneaux
Kevin Krenitsky MD
W. David Lee

Frequently Asked Questions About Lumicell’s Stock

plusminus
Can you buy Lumicell’s stock?
Lumicell is not publicly traded on NYSE or NASDAQ in the U.S. To buy Lumicell’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Lumicell’s stock?
Yes, you can sell stock of a private company like Lumicell. Forge can help you sell your Lumicell stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Lumicell’s stock price?
Lumicell is a privately held company and therefore does not have a public stock price. However, you may access Lumicell’s private market stock price with Forge Data.
plusminus
What is Lumicell’s stock ticker symbol?
Lumicell does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Lumicell : Completes Enrollment of Phase C Feasibility Trial for Breast Cancer Surgical Guidance Solution
Lumicell Raises $28.7M in Series C Financing |FinSMEs
Lumicell, Inc., a Wellesley, Mass.-based technology leader in the field of image-guided cancer surgery, raised $28.7M in Series C financing. Backers included Launch Capital and BlueIO. The company intends to use the funds to continue to develop its LUM system pipeline including plans to initiate its pivotal trial in breast cancer as well as expansion …
Lumicell raises $21m for image-guided cancer surgery tech
Lumicell has raised $20.7 million over the past three months, according to a regulatory document filed with SEC last week. More than 20 investors have contributed to the $26.5 million equity offering, the Wellesley, Mass.-based company reported, including one investor outside of the U.S. Get the full story at our sister site, Drug Delivery Business News.
Updated on: May 17, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.